TFA Therapeutics annual operating cash flow
2021
2022
2023
2024
2025
TFA Therapeutics Operating Cash Flow Growth & History (RAJAF)
TFA Therapeutics's operating cash flow was −$35,845 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$35,845 | −$347,851 | — |
| 2024 | 2024-12-31 | $312,006 | −$47,718 | −13.27% |
| 2023 | 2023-12-31 | $359,724 | $681,102 | — |
| 2022 | 2022-12-31 | −$321,378 | $43,985 | — |
| 2021 | 2021-12-31 | −$365,363 | — | — |
TFA Therapeutics operating cash flow trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's operating cash flow increased from −$365,363 to −$35,845, a change of $329,518.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗